How to Buy jhs Shares on Fincept?
You can buy JHS Svendgaard Laboratories Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: JHS Svendgaard Laboratories Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Jhs, including updates on board meetings and corporate actions.
JHS Svendgaard Laboratories Limited - https://www.svendgaard.com
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades, and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, hand sanitizers, laundry detergents, room fresheners, and denture tablet products under the Dr. Gold, Dr. Fresh, Boots, Lavoris, Peanuts, Amway, Dabur, Future Group, Apollo Pharmacy, Sandika Pharma, Elder Pharma, JL Morisons, Aquawhite, 6 Ten Store, Modi Care, Infectiguard, and Odonil brands. It also provides contract manufacturing services for oral care products of other brands. The company also exports its products. JHS Svendgaard Laboratories Limited was founded in 1997 and is based in New Delhi, India.
JHS Svendgaard Laboratories Limited Share Price Today
19.07
OPEN
19.50
HIGH
18.55
LOW
18.65
CLOSE
82 K
VOLUME
179 Cr
Market Cap
198633
Average Volume
Consumer Defensive
Sector
NSI
Exchange
JHS Svendgaard Laboratories Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: JHS Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
JHS Svendgaard Laboratories Limited |
JHS |
INE544H01014 |
Demerger |
11 Sep 2023 |
10 |
N/A |
JHS Svendgaard Laboratories Limited |
JHS |
INE544H01014 |
Annual General Meeting |
06 Sep 2019 |
10 |
N/A |
JHS Svendgaard Laboratories Limited |
JHS |
INE544H01014 |
Annual General Meeting |
03 Sep 2018 |
10 |
N/A |
JHS Svendgaard Laboratories Limited |
JHS |
INE544H01014 |
Annual General Meeting |
21 Aug 2017 |
10 |
N/A |
JHS Svendgaard Laboratories Limited |
JHS |
INE544H01014 |
Extra Ordinary General Meeting |
02 Jan 2017 |
10 |
N/A |
NSE: JHS Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
JHS |
26 Dec 2024, 12:56:42 |
Trading Window-XBRL |
Personal Care |
JHS |
26 Dec 2024, 12:55:39 |
Trading Window |
Personal Care |
JHS |
15 Nov 2024, 16:14:33 |
Copy of Newspaper Publication |
Personal Care |
JHS |
13 Nov 2024, 19:03:16 |
Appointment |
Personal Care |
JHS |
13 Nov 2024, 18:42:46 |
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
Personal Care |
NSE: JHS Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
JHS Svendgaard Laboratories Limited |
JHS |
08 Jan 2025, 16:45:00 |
08 Jan 2025, 16:45:00 |
|
JHS Svendgaard Laboratories Limited |
JHS |
11 Oct 2024, 15:58:00 |
11 Oct 2024, 15:58:00 |
|
JHS Svendgaard Laboratories Limited |
JHS |
16 Jul 2024, 15:10:00 |
16 Jul 2024, 15:10:00 |
|
JHS Svendgaard Laboratories Limited |
JHS |
21 Apr 2024, 13:58:00 |
21 Apr 2024, 14:15:00 |
|
JHS Svendgaard Laboratories Limited |
JHS |
20 Jan 2024, 17:45:00 |
20 Jan 2024, 18:15:00 |
NSE: JHS Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Executive Director-MD |
26 Sep 1972 |
08 Oct 2004 |
00051501 |
NIKHIL NANDA |
Active |
Independent Director |
13 Jan 1967 |
02 Jul 2015 |
00051534 |
MUKUL PATHAK |
Active |
Independent Director,Chairperson & Non-Executive Director |
21 Jul 1959 |
23 Jun 2020 |
00259537 |
RAJAGOPAL CHAKRAVARTHI VENKATIESH |
Active |
Independent Director |
10 Jun 1972 |
23 Jun 2020 |
02817283 |
KAPIL MINOCHA |
Active |
Non-Executive Director |
20 Jun 1953 |
27 May 2022 |
08232559 |
VINAY MITTAL |
Active |
NSE: JHS Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
Board Meeting Intimation |
JHS |
N/A |
INE544H01014 |
JHS Svendgaard Laboratories Limited |
07 Nov 2024, 15:44:15 |
JHS SVENDGAARD LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . |
JHS |
N/A |
INE544H01014 |
JHS Svendgaard Laboratories Limited |
06 Aug 2024, 18:17:50 |
JHS SVENDGAARD LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 04-Jun-2024 to consider Fund raising. |
JHS |
N/A |
INE544H01014 |
JHS Svendgaard Laboratories Limited |
30 May 2024, 16:12:32 |
Financial Results |
JHS |
N/A |
INE544H01014 |
JHS Svendgaard Laboratories Limited |
10 May 2024, 13:48:56 |
Financial Results |
JHS |
N/A |
INE544H01014 |
JHS Svendgaard Laboratories Limited |
05 Feb 2024, 11:00:03 |
NSE: JHS Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
JHS |
- |
INE544H01014 |
JHS Svendgaard Laboratories Limited |
07 Nov 2024, 00:00:00 |
To consider and approve the un-audited financial results for the quarter and half year ended September 30, 2024 |
Financial Results |
JHS |
- |
INE544H01014 |
JHS Svendgaard Laboratories Limited |
06 Aug 2024, 00:00:00 |
To consider and approve the Financial Results for the Quarter ended Jun 30, 2024. |
Fund Raising |
JHS |
- |
INE544H01014 |
JHS Svendgaard Laboratories Limited |
30 May 2024, 00:00:00 |
To consider and approve the proposal of raising of funds by way of issue of one or more instruments |
Fund Raising |
JHS |
- |
INE544H01014 |
JHS Svendgaard Laboratories Limited |
30 May 2024, 00:00:00 |
To consider and approve the proposal of raising of funds by way of issue of one or more instruments |
Financial Results |
JHS |
- |
INE544H01014 |
JHS Svendgaard Laboratories Limited |
10 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 |
NSE: JHS Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Non Current Deferred Revenue | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Available For Sale Securities | Financial Assets Designatedas Fair Value Through Profitor Loss | Long Term Equity Investment | Investmentsin Joint Venturesat Cost | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Assets Held For Sale Current | Current Deferred Assets | Restricted Cash | Prepaid Assets | Inventory | Inventories Adjustments Allowances | Other Inventories | Finished Goods | Work In Process | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 85,603,966.00 | 85,603,966.00 | 16,098,000.00 | 42,846,000.00 | 1,781,128,000.00 | 1,843,983,000.00 | 179,866,000.00 | 1,781,128,000.00 | 13,451,000.00 | 1,814,588,000.00 | 1,815,202,000.00 | 1,814,588,000.00 | 0.00 | 1,814,588,000.00 | 958,548,000.00 | 0.00 | 0.00 | 856,040,000.00 | 856,040,000.00 | 261,216,000.00 | 34,426,000.00 | 10,899,000.00 | 0.00 | 0.00 | 7,969,000.00 | 7,355,000.00 | 614,000.00 | 15,558,000.00 | 226,790,000.00 | 17,565,000.00 | 34,877,000.00 | 6,096,000.00 | 28,781,000.00 | 0.00 | 1,231,000.00 | 136,734,000.00 | 0.00 | 0.00 | 136,734,000.00 | 2,075,804,000.00 | 1,669,148,000.00 | 449,676,000.00 | 0.00 | 0.00 | 14,881,000.00 | 263,165,000.00 | 263,165,000.00 | 0.00 | 0.00 | 0.00 | 33,460,000.00 | 25,499,000.00 | 7,961,000.00 | 886,765,000.00 | 0.00 | 886,765,000.00 | 17,202,000.00 | 869,563,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 406,656,000.00 | 61,401,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 133,556,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 145,209,000.00 | 0.00 | 0.00 | 66,490,000.00 | 53,193,000.00 | 13,297,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 78,396,762.00 | 78,396,762.00 | 0.00 | 51,288,000.00 | 1,664,683,000.00 | 1,734,422,000.00 | 203,262,000.00 | 1,664,683,000.00 | 15,706,000.00 | 1,698,840,000.00 | 1,700,029,000.00 | 1,698,840,000.00 | 0.00 | 1,698,840,000.00 | 914,871,000.00 | -159,306,000.00 | 1,103,540,000.00 | 783,968,000.00 | 783,968,000.00 | 271,706,000.00 | 38,335,000.00 | 11,892,000.00 | 0.00 | 11,890,000.00 | 11,674,000.00 | 10,485,000.00 | 1,189,000.00 | 14,771,000.00 | 233,371,000.00 | 1,000.00 | 39,614,000.00 | 5,221,000.00 | 34,393,000.00 | 0.00 | 1,231,000.00 | 189,267,000.00 | 48,285,000.00 | 0.00 | 140,982,000.00 | 1,970,546,000.00 | 1,533,913,000.00 | -3,000.00 | 451,350,000.00 | 0.00 | 105,223,000.00 | 34,463,000.00 | 46,932,000.00 | 34,463,000.00 | 20,000.00 | 20,000.00 | 34,157,000.00 | 26,196,000.00 | 7,961,000.00 | 878,162,000.00 | -420,205,000.00 | 1,298,367,000.00 | 8,168,000.00 | 94,816,000.00 | 737,152,000.00 | 289,919,000.00 | 168,312,000.00 | 0.00 | 436,633,000.00 | 263,000.00 | 0.00 | 0.00 | 53,142,000.00 | 66,570,000.00 | 126,497,000.00 | -80,000.00 | 0.00 | 14,278,000.00 | 17,256,000.00 | 95,043,000.00 | 10,859,000.00 | 0.00 | 128,796,000.00 | 0.00 | 128,796,000.00 | 50,506,000.00 | 3,513,000.00 | 46,993,000.00 | 0.00 | 46,993,000.00 |
| 2024-03-31T00:00:00 | annual | 78,396,762.00 | 78,396,762.00 | 0.00 | 51,288,000.00 | 1,664,683,000.00 | 1,734,422,000.00 | 203,262,000.00 | 1,664,683,000.00 | 15,706,000.00 | 1,698,840,000.00 | 1,700,029,000.00 | 1,698,840,000.00 | 0.00 | 1,698,840,000.00 | 914,871,000.00 | -159,306,000.00 | 1,103,540,000.00 | 783,968,000.00 | 783,968,000.00 | 271,706,000.00 | 38,335,000.00 | 11,892,000.00 | 0.00 | 11,890,000.00 | 11,674,000.00 | 10,485,000.00 | 1,189,000.00 | 14,771,000.00 | 233,371,000.00 | 1,000.00 | 39,614,000.00 | 5,221,000.00 | 34,393,000.00 | 0.00 | 1,231,000.00 | 189,267,000.00 | 48,285,000.00 | 0.00 | 140,982,000.00 | 1,970,546,000.00 | 1,533,913,000.00 | -3,000.00 | 451,350,000.00 | 0.00 | 105,223,000.00 | 34,463,000.00 | 46,932,000.00 | 34,463,000.00 | 20,000.00 | 20,000.00 | 34,157,000.00 | 26,196,000.00 | 7,961,000.00 | 878,162,000.00 | -420,205,000.00 | 1,298,367,000.00 | 8,168,000.00 | 94,816,000.00 | 737,152,000.00 | 289,919,000.00 | 168,312,000.00 | 0.00 | 436,633,000.00 | 263,000.00 | 0.00 | 0.00 | 53,142,000.00 | 66,570,000.00 | 126,497,000.00 | -80,000.00 | 0.00 | 14,278,000.00 | 17,256,000.00 | 95,043,000.00 | 10,859,000.00 | 0.00 | 128,796,000.00 | 0.00 | 128,796,000.00 | 50,506,000.00 | 3,513,000.00 | 46,993,000.00 | 0.00 | 46,993,000.00 |
| 2023-09-30T00:00:00 | quarterly | 78,396,762.00 | 78,396,762.00 | 0.00 | 23,297,000.00 | 1,699,991,000.00 | 1,711,160,000.00 | 609,688,000.00 | 1,699,991,000.00 | 20,136,000.00 | 1,707,999,000.00 | 1,709,828,000.00 | 1,707,999,000.00 | 0.00 | 1,707,999,000.00 | 924,031,000.00 | 0.00 | 0.00 | 783,968,000.00 | 783,968,000.00 | 258,966,000.00 | 42,453,000.00 | 12,333,000.00 | 0.00 | 0.00 | 17,497,000.00 | 15,668,000.00 | 1,829,000.00 | 12,623,000.00 | 216,513,000.00 | 36,953,000.00 | 5,800,000.00 | 4,468,000.00 | 1,332,000.00 | 0.00 | 1,122,000.00 | 147,826,000.00 | 0.00 | 0.00 | 147,826,000.00 | 1,966,965,000.00 | 1,140,764,000.00 | 147,183,000.00 | 0.00 | 0.00 | 120,437,000.00 | 84,164,000.00 | 84,164,000.00 | 0.00 | 0.00 | 0.00 | 8,008,000.00 | 47,000.00 | 7,961,000.00 | 730,601,000.00 | 0.00 | 730,601,000.00 | 45,652,000.00 | 684,949,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 826,201,000.00 | 198,256,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 92,566,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,000.00 | 0.00 | 193,701,000.00 | 0.00 | 0.00 | 341,675,000.00 | 281,991,000.00 | 59,684,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 64,900,465.00 | 64,900,465.00 | 0.00 | 155,090,000.00 | 1,730,373,000.00 | 1,871,524,000.00 | 481,297,000.00 | 1,730,373,000.00 | 21,972,000.00 | 1,738,406,000.00 | 1,870,129,000.00 | 1,738,406,000.00 | 78,652,000.00 | 1,738,406,000.00 | 0.00 | -119,274,000.00 | 1,103,540,000.00 | 783,968,000.00 | 783,968,000.00 | 543,867,000.00 | 176,737,000.00 | -4,000.00 | 0.00 | 13,044,000.00 | 150,022,000.00 | 18,299,000.00 | 131,723,000.00 | 13,675,000.00 | 367,130,000.00 | 2,320,000.00 | 5,068,000.00 | 3,673,000.00 | 1,395,000.00 | 0.00 | 1,211,000.00 | 249,542,000.00 | 49,596,000.00 | 0.00 | 199,946,000.00 | 2,282,273,000.00 | 1,433,846,000.00 | -3,000.00 | 530,727,000.00 | 9,316,000.00 | 112,783,000.00 | 29,656,000.00 | 61,143,000.00 | 29,656,000.00 | 20,000.00 | 20,000.00 | 8,033,000.00 | 72,000.00 | 7,961,000.00 | 728,328,000.00 | -363,327,000.00 | 1,091,655,000.00 | 85,683,000.00 | 86,527,000.00 | 608,448,000.00 | 248,885,000.00 | 62,112,000.00 | 0.00 | 848,427,000.00 | 58,000.00 | 0.00 | 164,000.00 | 9,088,000.00 | 42,335,000.00 | 129,982,000.00 | -80,000.00 | 0.00 | 20,748,000.00 | 17,185,000.00 | 92,129,000.00 | 104,018,000.00 | 0.00 | 185,360,000.00 | -301,000.00 | 185,661,000.00 | 377,422,000.00 | 4,935,000.00 | 372,487,000.00 | 0.00 | 372,487,000.00 |
| 2023-03-31T00:00:00 | annual | 64,900,465.00 | 64,900,465.00 | 0.00 | 155,090,000.00 | 1,730,373,000.00 | 1,871,524,000.00 | 481,297,000.00 | 1,730,373,000.00 | 21,972,000.00 | 1,738,406,000.00 | 1,870,129,000.00 | 1,738,406,000.00 | 78,652,000.00 | 1,738,406,000.00 | 0.00 | -119,274,000.00 | 1,103,540,000.00 | 783,968,000.00 | 783,968,000.00 | 543,867,000.00 | 176,737,000.00 | -4,000.00 | 0.00 | 13,044,000.00 | 150,022,000.00 | 18,299,000.00 | 131,723,000.00 | 13,675,000.00 | 367,130,000.00 | 2,320,000.00 | 5,068,000.00 | 3,673,000.00 | 1,395,000.00 | 0.00 | 1,211,000.00 | 249,542,000.00 | 49,596,000.00 | 0.00 | 199,946,000.00 | 2,282,273,000.00 | 1,433,846,000.00 | -3,000.00 | 530,727,000.00 | 9,316,000.00 | 112,783,000.00 | 29,656,000.00 | 61,143,000.00 | 29,656,000.00 | 20,000.00 | 20,000.00 | 8,033,000.00 | 72,000.00 | 7,961,000.00 | 728,328,000.00 | -363,327,000.00 | 1,091,655,000.00 | 85,683,000.00 | 86,527,000.00 | 608,448,000.00 | 248,885,000.00 | 62,112,000.00 | 0.00 | 848,427,000.00 | 58,000.00 | 0.00 | 164,000.00 | 9,088,000.00 | 42,335,000.00 | 129,982,000.00 | -80,000.00 | 0.00 | 20,748,000.00 | 17,185,000.00 | 92,129,000.00 | 104,018,000.00 | 0.00 | 185,360,000.00 | -301,000.00 | 185,661,000.00 | 377,422,000.00 | 4,935,000.00 | 372,487,000.00 | 0.00 | 372,487,000.00 |
| 2022-03-31T00:00:00 | annual | 64,900,465.00 | 64,900,465.00 | 0.00 | 61,817,000.00 | 1,847,731,000.00 | 1,865,876,000.00 | 600,419,000.00 | 1,847,731,000.00 | 54,962,000.00 | 1,859,021,000.00 | 1,863,841,000.00 | 1,950,459,000.00 | 91,438,000.00 | 1,859,021,000.00 | 0.00 | 141,166,000.00 | 1,041,608,000.00 | 649,005,000.00 | 649,005,000.00 | 269,459,000.00 | 80,368,000.00 | -1,000.00 | 15,392,000.00 | 14,399,000.00 | 50,578,000.00 | 45,758,000.00 | 4,820,000.00 | 15,392,000.00 | 189,091,000.00 | 15,315,000.00 | 11,239,000.00 | 9,204,000.00 | 2,035,000.00 | 2,148,000.00 | 2,148,000.00 | 165,136,000.00 | 26,756,000.00 | 0.00 | 138,380,000.00 | 2,219,918,000.00 | 1,430,409,000.00 | 1,000.00 | 536,331,000.00 | 18,701,000.00 | 71,104,000.00 | 11,790,000.00 | 27,000.00 | 11,763,000.00 | 0.00 | 0.00 | 11,290,000.00 | 221,000.00 | 11,069,000.00 | 773,491,000.00 | -315,583,000.00 | 1,089,074,000.00 | 199,589,000.00 | 88,665,000.00 | 524,350,000.00 | 220,141,000.00 | 56,329,000.00 | 0.00 | 789,510,000.00 | 4,000.00 | 0.00 | 303,000.00 | 8,830,000.00 | 156,514,000.00 | 121,024,000.00 | -1,035,000.00 | 28,249,000.00 | 24,020,000.00 | 25,165,000.00 | 72,874,000.00 | 241,267,000.00 | 215,000.00 | 181,162,000.00 | 0.00 | 181,162,000.00 | 80,191,000.00 | 27,310,000.00 | 52,881,000.00 | 220,000.00 | 52,661,000.00 |
| 2021-03-31T00:00:00 | annual | 64,400,465.00 | 64,400,465.00 | 0.00 | 70,111,000.00 | 1,875,485,000.00 | 1,895,317,000.00 | 978,214,000.00 | 1,875,485,000.00 | 61,749,000.00 | 1,886,955,000.00 | 1,891,651,000.00 | 1,979,608,000.00 | 92,653,000.00 | 1,886,955,000.00 | 2,500,000.00 | 177,016,000.00 | 1,036,608,000.00 | 644,005,000.00 | 644,005,000.00 | 299,969,000.00 | 68,666,000.00 | 0.00 | 13,625,000.00 | 0.00 | 55,041,000.00 | 50,345,000.00 | 4,696,000.00 | 13,625,000.00 | 231,303,000.00 | 4,000.00 | 15,070,000.00 | 11,404,000.00 | 3,666,000.00 | 1,440,000.00 | 1,440,000.00 | 199,644,000.00 | 39,837,000.00 | 0.00 | 159,807,000.00 | 2,279,577,000.00 | 1,070,060,000.00 | -2,000.00 | 109,144,000.00 | 109,763,000.00 | 105,340,000.00 | 0.00 | 25,000.00 | 0.00 | 0.00 | 0.00 | 11,470,000.00 | 401,000.00 | 11,069,000.00 | 709,888,000.00 | -256,094,000.00 | 965,982,000.00 | 89,162,000.00 | 97,698,000.00 | 502,652,000.00 | 220,141,000.00 | 56,329,000.00 | 0.00 | 1,209,517,000.00 | 69,000.00 | 0.00 | 224,000.00 | 1,560,000.00 | 160,413,000.00 | 116,385,000.00 | -4,744,000.00 | 31,378,000.00 | 28,280,000.00 | 13,084,000.00 | 79,765,000.00 | 113,327,000.00 | 59,000.00 | 587,100,000.00 | 0.00 | 587,100,000.00 | 230,380,000.00 | 22,456,000.00 | 207,924,000.00 | 0.00 | 207,924,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 1,629,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 65,985,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12,230,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,517,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,142,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,511,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 205,000.00 | 0.00 |
NSE: JHS Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Net Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net Business Purchase And Sale | Purchase Of Business | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Gain Loss On Investment Securities | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -401,168,000.00 | 0.00 | -315,326,000.00 | 91,047,000.00 | -1,000.00 | 372,487,000.00 | -281,440,000.00 | 21,738,000.00 | -1,000.00 | -4,120,000.00 | 0.00 | 0.00 | 31,793,000.00 | 32,997,000.00 | -1,204,000.00 | -217,336,000.00 | 16,747,000.00 | 5,607,000.00 | -3,000,000.00 | 0.00 | -3,000,000.00 | 0.00 | 0.00 | -237,264,000.00 | 78,062,000.00 | -315,326,000.00 | -85,842,000.00 | 0.00 | -108,849,000.00 | -132,339,000.00 | 44,408,000.00 | -81,079,000.00 | 3,485,000.00 | 55,559,000.00 | -3,175,000.00 | -5,214,000.00 | 63,458,000.00 | 1,344,000.00 | 62,114,000.00 | 0.00 | -1,000.00 | -15,000.00 | -34,286,000.00 |
| 2023-03-31T00:00:00 | annual | 89,426,000.00 | 0.00 | -143,436,000.00 | 375,117,000.00 | 2,630,000.00 | 51,854,000.00 | 320,633,000.00 | -8,999,000.00 | 0.00 | -2,446,000.00 | 0.00 | 0.00 | -2,068,000.00 | -640,000.00 | -1,428,000.00 | 96,770,000.00 | 11,429,000.00 | 9,896,000.00 | -7,188,000.00 | 3,091,000.00 | -7,188,000.00 | 0.00 | 0.00 | -25,851,000.00 | 117,585,000.00 | -143,436,000.00 | 232,862,000.00 | 0.00 | 236,524,000.00 | 121,786,000.00 | 40,027,000.00 | 100,968,000.00 | -12,478,000.00 | -11,124,000.00 | -8,439,000.00 | 183,631,000.00 | 60,167,000.00 | 149,000.00 | 60,018,000.00 | -416,000.00 | -8,999,000.00 | -400,000.00 | -229,511,000.00 |
| 2022-03-31T00:00:00 | annual | -158,748,000.00 | -2,498,000.00 | -67,387,000.00 | 52,881,000.00 | 0.00 | 207,924,000.00 | -155,043,000.00 | -16,716,000.00 | 0.00 | -10,106,000.00 | -2,498,000.00 | -2,498,000.00 | 2,925,000.00 | 2,801,000.00 | 124,000.00 | -46,966,000.00 | -3,719,000.00 | 24,803,000.00 | -4,017,000.00 | 0.00 | -4,017,000.00 | 0.00 | 0.00 | -64,033,000.00 | 3,354,000.00 | -67,387,000.00 | -91,361,000.00 | -3,078,000.00 | -91,100,000.00 | -139,241,000.00 | -223,683,000.00 | -33,875,000.00 | -7,207,000.00 | 309,593,000.00 | -59,322,000.00 | -4,912,000.00 | 70,522,000.00 | 7,240,000.00 | 63,282,000.00 | 324,000.00 | -6,529,000.00 | 0.00 | 1,030,000.00 |
| 2021-03-31T00:00:00 | annual | 36,963,000.00 | 117,500,000.00 | -83,327,000.00 | 207,924,000.00 | 0.00 | 6,798,000.00 | 201,126,000.00 | 103,088,000.00 | 54,000.00 | -6,301,000.00 | 117,500,000.00 | 117,500,000.00 | 1,287,000.00 | 1,569,000.00 | -282,000.00 | -22,252,000.00 | 175,000.00 | 2,897,000.00 | 40,793,000.00 | 199,287,000.00 | -158,494,000.00 | 0.00 | 0.00 | -65,978,000.00 | 17,349,000.00 | -83,327,000.00 | 120,290,000.00 | -7,734,000.00 | 53,883,000.00 | -33,561,000.00 | -28,634,000.00 | -195,889,000.00 | -58,719,000.00 | 368,334,000.00 | -11,119,000.00 | -36,512,000.00 | 72,546,000.00 | 214,000.00 | 72,332,000.00 | 954,000.00 | 6,166,000.00 | 503,000.00 | 9,678,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 103,885,000.00 | 0.00 | 0.00 | 1,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 103,885,000.00 | 103,885,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 39,407,000.00 | 0.00 | -15,000,000.00 | -15,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,768,000.00 | 0.00 | 0.00 | 0.00 |
NSE: JHS Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Research And Development | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 0.23 | 0.00 | 2.58 | 0.76 | 0.76 | -4.06 | 6.35 | 49.45 | 3.34 | -3.00 | 0.10 | 0.42 | 0.56 | -4.59 | -4.06 | 76.07 | 0.27 | 7.84 | 7.84 | 0.00 | 0.00 | -4.06 | -4.06 | 0.00 | -4.06 | 0.00 | -4.06 | -4.06 | 0.63 | -3.43 | 2.10 | 0.47 | -0.70 | 0.22 | 0.10 | 0.04 | 0.42 | 0.56 | -6.27 | 26.62 | 8.97 | 6.35 | 0.13 | 6.21 | 0.00 | 2.91 | 1.17 | 1.74 | 0.27 | 20.36 | 49.45 | 69.81 | 69.81 |
| 2023-03-31T00:00:00 | annual | -4.39 | 0.00 | 2.15 | -18.58 | -18.58 | -17.52 | 6.02 | 67.54 | -16.43 | -22.45 | 0.44 | 0.50 | 0.99 | -3.34 | -17.52 | 98.68 | 0.10 | 7.84 | 7.84 | 0.00 | 0.00 | -17.52 | -17.52 | 0.00 | -17.52 | 1.31 | -17.52 | -17.52 | -5.43 | -22.95 | 8.89 | -18.65 | 16.03 | 2.62 | 0.44 | 0.05 | 0.50 | 0.99 | -14.60 | 31.15 | 8.38 | 6.02 | 0.01 | 6.00 | 0.07 | 7.26 | 2.76 | 4.50 | 0.10 | 16.55 | 67.54 | 84.08 | 84.08 |
| 2022-03-31T00:00:00 | annual | 0.05 | 0.00 | 8.27 | 0.15 | 0.15 | -4.05 | 7.05 | 65.32 | 8.42 | 1.37 | 0.81 | 1.27 | 2.20 | -4.16 | -4.05 | 90.52 | 0.00 | 6.45 | 6.45 | 0.00 | 0.00 | -4.05 | -4.05 | 0.00 | -4.05 | 0.24 | -4.29 | -4.29 | 4.39 | 0.10 | 3.52 | 0.00 | 0.00 | 0.00 | 0.81 | 0.12 | 1.27 | 2.20 | -5.03 | 25.19 | 5.60 | 7.05 | 0.72 | 6.33 | 0.07 | 2.40 | 0.71 | 1.69 | 0.00 | 20.17 | 65.32 | 85.49 | 85.49 |
| 2021-03-31T00:00:00 | annual | -0.94 | 0.00 | 12.60 | -3.14 | -3.14 | 1.20 | 7.25 | 73.67 | 9.46 | 2.21 | -0.41 | 1.24 | 0.83 | 3.39 | 1.20 | 96.40 | 0.01 | 6.16 | 6.14 | 0.00 | 0.00 | 1.20 | 1.20 | 0.00 | 1.20 | -0.14 | 1.34 | 1.34 | -0.37 | 0.97 | 1.58 | -3.34 | 0.05 | 3.29 | -0.41 | 0.00 | 1.24 | 0.83 | 3.67 | 22.73 | 3.81 | 7.25 | 0.02 | 7.23 | 0.00 | 2.45 | 0.69 | 1.76 | 0.01 | 26.40 | 73.67 | 100.07 | 100.07 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
-1.46
P/E
N/A
P/B
0.9621597
Dividend Yield
N/A
Market Cap
178.82 Cr.
Face Value
21.67
Book Value
21.67
ROE
-2.51%
EBITDA Growth
6.85 Cr.
Debt/Equity
3.719
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of jhs?
The market capitalization of JHS Svendgaard Laboratories Limited is ₹179 Cr as of 05 Feb 2025.
What are the PE and PB ratios of JHS Svendgaard Laboratories Limited?
The PE and PB ratios of JHS Svendgaard Laboratories Limited are Not Available and 0.9621597 respectively as of 05 Feb 2025.
What is the 52 Week High of JHS Svendgaard Laboratories Limited?
The 52-week high of JHS Svendgaard Laboratories Limited is ₹39.5 as of 05 Feb 2025.
What is the 52 Week Low of JHS Svendgaard Laboratories Limited?
The 52-week low of JHS Svendgaard Laboratories Limited is ₹15.55 as of 05 Feb 2025.
What are the earnings per share (EPS) for JHS Svendgaard Laboratories Limited?
The Earnings Per Share (EPS) of JHS Svendgaard Laboratories Limited is ₹-1.46 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of JHS Svendgaard Laboratories Limited?
The Return on Equity (ROE) of JHS Svendgaard Laboratories Limited is -2.51% as per the most recent financial year data. Explore more on Fincept.